Probiotics and carriage of Streptococcus pneumoniae serotypes in Danish children, a double-blind randomized

Sine Fjeldhøj1, Rikke Pilmann Laursen2, Anni Larnkjær2

  • 1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, 2300, Denmark.

Scientific Reports
|October 17, 2018
PubMed

Insights

Probiotics did not affect Streptococcus pneumoniae carriage in Danish children. Carriage rates increased significantly, with children carrying serotypes not typically causing invasive pneumococcal disease (IPD) in the elderly.

Area of Science:

  • Microbiology
  • Pediatrics
  • Immunology

Background:

  • Streptococcus pneumoniae carriage is common in young children.
  • Understanding carriage dynamics is crucial for preventing invasive pneumococcal disease (IPD).
  • Probiotics are explored for their potential impact on respiratory pathogens.

Purpose of the Study:

  • To investigate Streptococcus pneumoniae carriage in healthy Danish children aged 8-19 months.
  • To assess the efficacy of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis on pneumococcal carriage.
  • To analyze risk factors for carriage and compare findings with invasive pneumococcal disease (IPD) data.

Main Methods:

  • A double-blind, randomized controlled trial (ProbiComp study) involving 290 children.
  • Children received probiotics or placebo for 6 months during daycare enrollment.
  • Pneumococci identification and serotyping using optochin sensitivity, bile solubility, and Quellung reaction.

Main Results:

  • The overall carriage rate of S. pneumoniae increased from 26.0% at baseline to 67.4% at the end of the intervention.
  • No significant difference in pneumococcal carriage was observed between the probiotic and placebo groups (p=0.508).
  • Children carried non-vaccine serotypes prevalent in younger children, but not those common in elderly IPD cases.

Conclusions:

  • Probiotics Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis did not significantly alter pneumococcal carriage in this cohort.
  • Danish children aged 8-19 months primarily carry S. pneumoniae serotypes not associated with high IPD rates in the elderly.
  • Other age groups may be more significant reservoirs for pneumococcal serotypes causing IPD in the elderly, warranting further investigation.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.4K
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
892
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
420